Open house Arzneimittelrabattverträge Glatirameracetat in der Darreichungsform Fertigpen, ATC L03AX13

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Apr 05, 2027 · 220 days left·Open·Supplies·Framework

Structured notice only

Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Glatirameracetat in der Darreichungsform Fertigpen, ATC L03AX13

50/100

Opportunity Score

Needs reviewLow complexity

SuppliesFrameworkOpen

Why this score?

Opportunity

50 / 100

Complexity

30 / 100

Risk factors

No estimated value or minimum guarantee provided. Revenue potential is unclear.

Open-house agreements automatically terminate if a nationally or regionally awarded discount contract for the same subs...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Overview

Moderate opportunity

Key Facts

Framework procurement
Supplies contract
1 lot
Duration until May 2027
Conclusion of non-exclusive discount agreements for Glatiramer acetate in pre-filled pen dosage form (ATC L03AX13).
Contracts are identical and non-negotiable for all pharmaceutical companies that meet eligibility criteria.

Show full summary

Open-house model for non-exclusive discount agreements on Glatiramer acetate (pre-filled pen, ATC L03AX13) with AOK Bayern. All qualifying pharmaceutical companies can join identical, non-negotiable contracts. Contract period: 1 June 2025 to 31 May 2027, with possible later start. No estimated value provided.

Risks

No estimated value or minimum guarantee provided. Revenue potential is unclear.

Open-house agreements automatically terminate if a nationally or regionally awarded discount contract for the same subs...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

Must be a pharmaceutical company (pharmazeutischer Unternehmer).

Administrative

Submit signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
Submit signed contract and annex specifying the medicinal products.

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria; this is an open-house model where all eligible participants are accepted.

Buyer

Name

AOK Bayern - Die Gesundheitskasse

Location

München, DEU

[email protected]

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house Arzneimittelrabattverträge Glatirameracetat in der Darreichungsform Fertigpen, ATC L03AX13

Single lot covering discount agreements for Glatiramer acetate pre-filled pen. Framework agreement with multiple contractors. Duration 24 months.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

May 2025 - May 2027

Procurement Details

Publication date: 15 Apr 2025
Languages: German

Reference metadata

Legal basis: 32014L0024

Reference IDs

Tender ID: 249001-2025

Documents (2)

Procurement document 1 Submission portal 1

Similar tenders

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3